Morgan Stanley downgrades Berkeley, Barratt Redrow

(Sharecast News) - Morgan Stanley downgraded Berkeley Group and Barratt Redrow on Tuesday and cut price targets across the board, as it took a more cautious stance on housebuilders. The bank pointed to rising macro risks, fading rate support and the re-emergence of cost uncertainty.

"Valuations are cheap, but catalysts are scarce," it said. "Absent clearer rate support, demand visibility is limited and we reset estimates lower, despite depressed sector valuations."

Morgan Stanley downgraded Berkeley to 'underweight' from 'equalweight' and slashed the price target to 2,990p from 3,840p. It noted that Berkeley has cut profit forecasts, paused land acquisition and prioritised balance sheet strength over growth amid weak London and South East demand.

The bank said its 2027 pre-tax profit estimate sits 6% below consensus.

It downgraded Barratt Redrow to 'equalweight' from 'overweight' and cut the price target to 300p from 430p. Morgan Stanley said that while scale and a multi-brand platform offer strategic flexibility, the ability to fully realise revenue synergies is constrained in a weak demand environment, leaving performance increasingly macro-driven.

The bank is 'overweight' Persimmon but cut the price target to 1,390p from 1,610p. "We prefer Persimmon as the cleanest way to gain exposure to a volume-led recovery, should rate conditions ease," it said.

"Persimmon offers above-average margins and returns, strong cash generation and a simpler operating model, with limited exposure to London.

"While near-term growth remains constrained, valuation looks appealing relative to peers, and we see a more favourable risk/reward balance if conditions stabilise."

Morgan Stanley kept its 'underweight' rating on Taylor Wimpey and cut the price target to 80p from 90p, as it argued that upside is increasingly limited in a weak demand environment, with operating leverage constrained and performance tied heavily to macro conditions.

The bank remained 'equalweight' on Vistry and reduced the price target to 380p from 510p.

"At Vistry, while recent earnings downgrades and execution risk limit near-term upside, its partnership-led model could provide some relative resilience through the cycle, resulting in a more balanced risk-reward at current levels," it said.